Collectively, while a cytoprotective role of topotecan-mediated autophagy and its potential targeting as a possible therapeutic strategy to increase the effectiveness of topotecan-based therapy might have utility in p53 wild-type cells, this does not appear to be the case in tumor cells lacking functional p53. Here, TP53 is linked to neoplasm.